E-LIB Suche - Ergebnisse für: Awad, A.G.

1

COVID 19 at ischemic heart disease, A retrospective study:

Vlachopoulou, M. ; Chatzis, G. ; Karish, M.A....
Atherosclerosis. 331 (2021) - p. e232 , 2021

Link: https://doi.org/10.1016/..

2

Physica status solidi

Volume 81, Number 2: February 16 Physica status solidi ; Volume 81, Number 2, A

Abdurakhmanova, S. N ; Abushov, S. A ; Acharya, B. S... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

3

A Comparative Study between Sugammadex versus Neostigmine a..:

Youssef, G F K ; Elshafie, M A A ; Rabie, A H A.
QJM: An International Journal of Medicine. 113 (2020) Supplement_1 - p. , 2020

Link: https://doi.org/10.1093/..

4

Effect of Salinity and PH on the Industrial Effluent Treatm..:

Mohamed, E. F. ; Awad, G. ; Andriantsiferana, C..
Environmental Management and Sustainable Development. 8 (2019) 1 - p. 77 , 2019

Link: https://doi.org/10.5296/..

5

Transition metals-incorporated zeolites as environmental ca..:

Mohamed, E. F. ; Awad, G. ; Zaitan, H...
Environmental Technology. 39 (2017) 7 - p. 878-886 , 2017

Link: https://doi.org/10.1080/..

6

Evaluation of health related quality of life outcomes among..:

Awad, G. ; Hassan, M. ; Loebel, A....
Value in Health. 16 (2013) 3 - p. A64 , 2013

Link: https://doi.org/10.1016/..

7

Methodological Issues in Negative Symptom Trials:

Marder, S. R. ; Daniel, D. G. ; Alphs, L...
Schizophrenia Bulletin. 37 (2011) 2 - p. 250-254 , 2011

Link: https://doi.org/10.1093/..

8

What Is Causing the Reduced Drug-Placebo Difference in Rece..:

Kemp, A. S. ; Schooler, N. R. ; Kalali, A. H....
Schizophrenia Bulletin. 36 (2008) 3 - p. 504-509 , 2008

Link: https://doi.org/10.1093/..

9

Neuroleptic dysphoria: revisiting the concept 50 years late:

Awad, A. G. ; Voruganti, L. N. P.
Acta Psychiatrica Scandinavica. 111 (2005) s427 - p. 6-13 , 2005

Link: https://doi.org/10.1111/..

10

Brain imaging research on subjective responses to psychotro..:

Voruganti, L. P. ; Awad, A. G.
Acta Psychiatrica Scandinavica. 111 (2005) s427 - p. 22-28 , 2005

Link: https://doi.org/10.1111/..

11

Neuroleptic dysphoria: towards a new synthesis:

Voruganti, L. ; Awad, A. G.
Psychopharmacology. 171 (2004) 2 - p. 121-132 , 2004

Link: https://doi.org/10.1007/..

12

The subjective/objective dichotomy in schizophrenia - relev..:

, In: Zukunftsperspektiven in Psychiatrie und Psychotherapie,

Awad, A. G. ; Voruganti, L. N. P. - p. 21-27 , 2002

Link: https://doi.org/10.1007/..

13

Patient attitude toward therapy after switch to ziprasidone..:

Awad, G. ; Voruganti, L.N.P. ; Dugar, A.
European Neuropsychopharmacology. 11 (2001) - p. S275-S276 , 2001

Link: https://doi.org/10.1016/..

14

PMH3: PATIENT MEDICATION ATTITUDE AFTER SWITCHING TOZIPRASI..:

Dugar, A ; Awad, G ; Voruganti, LNP
Value in Health. 4 (2001) 6 - p. 451-452 , 2001

Link: https://doi.org/10.1016/..

15

Antipsychotic medications in schizophrenia and how satisfie..:

Awad, A.G. ; Voruganti, L.N.P.
Schizophrenia Research. 41 (2000) 1 - p. 224 , 2000

Link: https://doi.org/10.1016/..